Trexall Articles

Arava shows early benefit in RA

22 June 2000

Two new therapies for Crohn's studied

2 June 2000

BioNumerik presents Ph I data with karenitecin

24 May 2000

Immunex' cancer drug pricing investigated

22 March 2000

NEJM warns against breast cancer therapy

8 March 2000

Enbrel gains Euro approval for arthritis

8 February 2000

BASF moves into Phase III with D2E7

7 February 2000

Amgen files first regulatory dossiers for NESP and Kineret

27 January 2000

New Amgen RA drug candidates, data presented at ACR

18 November 1999

Centocor's Remicade, now backed for RA, will be first competitor for Enbrel

17 November 1999

Two-year data support Arava activity in RA

15 November 1999

Centocor files for RA Remicade indication

21 October 1999

Centocor unblinds Remicade RA trial

22 September 1999

Epirubicin cleared in USA for node-positive early breast cancer

21 September 1999

B-MS' Taxol improves survival in breast cancer

6 August 1999

Chugai reports recent filings and R&D pipeline

2 August 1999

Amgen soars on arthritis drug progress and strong financials

15 July 1999

Euro pharma firms spell out plans for future growth to US investors

17 June 1999

Positive data with CAT, BASF arthritis drug

15 June 1999

Pharmacia & Upjohn's epirubicin gains partial backing for breast cancer

10 June 1999

One-year RA data for Centocor's Remicade

9 June 1999

FDA approves Enbrel for juvenile arthritis, despite warning - Updated story

3 June 1999

Biogen looking to bring additional drugs to market on the back of Avonex'

3 June 1999

Goserelin may have place in early premenopausal breast cancer

20 May 1999

Enbrel needs further study on infections issue; new data support early use

13 May 1999

FDA gives go-ahead to Prosorba column in rheumatoid arthritis patients

18 March 1999

Centocor files for Remicade in arthritis

27 January 1999

UPDATED STORY - SmithKline Beecham's Lyme disease vaccine set for launch in

6 January 1999

SB postpones trial of arthritis antibody

24 December 1998

Lachema In Paclitaxel Pact With Xechem

1 December 1998

Remicade Effective In Rheumatoid Arthritis

11 November 1998

Immunex' Enbrel Launched In USA For Arthritis

3 November 1998

Prosorba Column Given Go-Ahead By FDA Panel

2 November 1998

Wyeth's Isovorin In UK

28 October 1998

DepoTech Submits NDA For DepoCyt Again

13 October 1998

The Emerging Role Of Anticytokine Therapy

1 October 1998

Enbrel Recommended For Approval By US Panel

21 September 1998

Enbrel Recommended To FDA

17 September 1998

First Launch Of HMR's Arava In USA

14 September 1998

Chugai Restructures For The 21st Century

28 August 1998

HMR's Arava Moves Closer To US Approval

12 August 1998

Angiotech To Study Paclitaxel In Arthritis

18 June 1998

FDA Says Depotech's DepoCyt "Non-Approvable"

27 May 1998

France's Fournier Gets Ready To Blossom

12 March 1998

Product News In Brief

12 March 1998

Anergen Reports Progress With Arthritis Vaccine

12 March 1998

Biotech Promise For Rheumatoid Arthritis

26 February 1998

Cypress' Prosorba Effective In Rheumatoid Arthritis

29 January 1998

Centocor's Avakine, Efficacy In RA?

13 November 1997

Licensing Opportunity From Amgen

10 September 1997

Neoral Launched For Arthritis In USA

31 July 1997

Enbrel Effective In Arthritis, Says Study

23 July 1997

Centocor Reveals Positive cA2 Data

19 May 1997

Neoral Backed For Severe Arthritis By FDA Panel

10 February 1997

DepoTech Starts Filing NDA For DepoCyt

2 December 1996

DepoCyt Heading For Commercialization

28 October 1996

SuperGen Acquires Rights To Barr Labs Anticancer Products

5 August 1996

Autoimmune's Oral Tolerance Drugs Reach Pivotal Stage

20 May 1996

Rheumatoid Arthritis And Disease Management

22 April 1996

FDA Approval For Immunex' Etoposide

25 March 1996

Agouron Pushes Viracept Towards Pivotal Trials

15 January 1996

Evolving Treatment For Colorectal Cancer

20 November 1995

Sandoz MDR Drug Shows Promise In Early Trials

13 November 1995

Delta Pharma starts trials of methotrexate and misoprostol

11 September 1995

Phase III Leflunomide Trials To Complete By Year-End

26 June 1995

IntraDose Products In Esophageal Cancer

29 May 1995

Receptagen Begins Growth Blocker Trials

27 February 1995

Receptagen Develops IV CoQ10 Formulation

21 November 1994

Abortion Drugs Under FDA Authorization

31 October 1994

Phase II Results With Centocor's CenTNF

31 October 1994

Ciba's Actigall Not Ready For Cirrhosis Approval, Says FDA

8 August 1994

Vertex Predicts Four Drugs In Trials By End-1994

25 July 1994

METHOTREXATE AND LIVER BIOPSIES

25 July 1994

ROCHE'S SORIATANE TO REPLACE TEGOSIN?

28 February 1994

IMMUNEX AIMS FOR THREE DRUGS IN CLINIC IN 1994

21 February 1994

ENZON'S ONCASPAR APPROVED IN USA

14 February 1994

CENTOCOR ARTHRITIS DRUG HAILED IN UK TRIALS

7 February 1994

ZENECA STARTS PH II TRIALS OF ZD1694

24 January 1994

NEW DRUG OPTION FOR ARTHRITIS THERAPY

19 July 1993

NEUTREXIN TREATMENT IND

21 June 1993

GLAXO COMPROMISES OVER ONDANSETRON PATENT

26 April 1993

WORLD ANTICANCER/ IMMUNOLOGY MARKET

8 February 1993

TAKEDA'S TNP-351 IN PHASE II TRIALS

1 February 1993

MYLAN'S GENERIC METHOTREXATE

25 May 1992

POSITIVE FORECAST FOR GENTA'S TECHNOLOGY

18 May 1992

METHOTREXATE IN JUVENILE ARTHRITIS

27 April 1992

Showing 201-286 of 286 articles

Go to beginningPreviousNextGo to end